Taken together, inhibition of pro-inflammatory cytokines including IL-1β andTNF-α as well as reduction of the Th2 cytokine IL-13 level might be effective against the overall stages of AD [32, 33]. This evidence concerns the gene IL1B and Alzheimer disease.